OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 2, pp. 326-337
Closed Access | Times Cited: 7
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 2, pp. 326-337
Closed Access | Times Cited: 7
Showing 7 citing articles:
Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling
Soo-Jeung Park, Josefina Garcia Diaz, Tina Comlekoglu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Soo-Jeung Park, Josefina Garcia Diaz, Tina Comlekoglu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA)
Saade Abdalkareem Jasim, Omar Dheyauldeen Salahdin, H. Malathi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3031-3051
Closed Access | Times Cited: 2
Saade Abdalkareem Jasim, Omar Dheyauldeen Salahdin, H. Malathi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3031-3051
Closed Access | Times Cited: 2
Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients
Weihua Cao, Y Q Zhang, Xinxin Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1158-1168
Closed Access | Times Cited: 1
Weihua Cao, Y Q Zhang, Xinxin Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1158-1168
Closed Access | Times Cited: 1
Matr3 Promotes Liver Cancer Progression by Suppressing Dhx58–Mediated Type I Interferon Response
Zhaofeng Xiao, Huan Chen, Nan Xu, et al.
(2024)
Closed Access
Zhaofeng Xiao, Huan Chen, Nan Xu, et al.
(2024)
Closed Access
Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization
Xie Shuangshuang, Cuiyun Wang, Xiaoyan Liu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 9
Open Access
Xie Shuangshuang, Cuiyun Wang, Xiaoyan Liu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 9
Open Access
Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients
Weihua Cao, Y Q Zhang, Xinxin Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1338-1348
Open Access
Weihua Cao, Y Q Zhang, Xinxin Li, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1338-1348
Open Access
ACTR10 Overexpression Facilitates the Progression and Tyrosine Kinase Inhibitor Resistance in Hepatocellular Carcinoma
Jie Luo, Kai Qin, Rong‐Rong He, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 6, pp. 882-901
Open Access
Jie Luo, Kai Qin, Rong‐Rong He, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 6, pp. 882-901
Open Access
